5 结果
FIELD OF THE INVENTION
This invention relates to polypeptides of the triacylglycerol lipase family, to nucleic acids encoding said polypeptides, to antisense sequences derived from said nucleic acids, and to antibodies against said polypeptides. This invention also relates to the preparation of said
TECHNICAL FIELD
The present invention is directed to enzymes, methods to purify, and obtain such enzymes, amino acid and nucleic acid sequences related thereto, and methods of use for such compositions in genetic engineering applications.
BACKGROUND OF THE INVENTION
Triacylglycerol (TAG) is thought
INCORPORATION OF SEQUENCE LISTING
A paper copy of the Sequence Listing and a computer readable form (CRF) of the sequence listing on diskette, containing the file named "seqlisting 16515-143.txt", which is 51.344 bytes in size (measured in MS-DOS), and which was recorded on Apr. 15, 2002, are herein
The present invention relates to a nutritional or therapeutic composition for oral administration which comprises a naturally occurring precursor that is metabolised to a compound having anandamide activity for use as a medicament or nutritional product, a method of production of the composition,
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is related to a method of treating or preventing hyperlipidemia. Particularly, the present invention is related to a method of treating or preventing hyperlipidemia with caffeamide derivatives.
2. The Prior Arts
Diabetes